Summary

The global Ex Vivo Human Skin Models market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Compared with in vitro skin models, ex vivo models can be more accurate on representing the human skin in some case, such as the effect of the extracellular matrix (ECM) in terms of structure, cell signaling mechanisms and the processes of metabolism, the incorporation of skin appendages such as hair follicles and sweat glands, and the effects of dermal absorption. Ex vivo human skin is more appropriate for certain types of research, use of whole skin biopsies in culture allows the effect of individual ingredients and formulations, transdermal delivery, topical penetration and percutaneous absorption to be tested in an environment more closely mimicking normal skin.
In 2025, the North America Ex Vivo Human Skin Models market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Ex Vivo Human Skin Models include Genoskin, MatTek Life Sciences, Creative Bioarray, EpiSkin, Reprocell, Alcyomics, Epistem, QIMA Life Sciences, Extherid Biosciences, Perfectus Biomed, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Ex Vivo Human Skin Models market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Genoskin
MatTek Life Sciences
Creative Bioarray
EpiSkin
Reprocell
Alcyomics
Epistem
QIMA Life Sciences
Extherid Biosciences
Perfectus Biomed
Xenometrix
Syntivia
Creative Biolabs
Segment by Type
Products
Customized Testing Services
Segment by Application
Pharmaceutical
Cosmetic
Others
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Ex Vivo Human Skin Models sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Ex Vivo Human Skin Models manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Ex Vivo Human Skin Models product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Ex Vivo Human Skin Models value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Ex Vivo Human Skin Models Product Scope
1.2 Ex Vivo Human Skin Models by Type
1.2.1 Global Ex Vivo Human Skin Models Sales by Type (2021, 2025 & 2032)
1.2.2 Products
1.2.3 Customized Testing Services
1.3 Ex Vivo Human Skin Models by Application
1.3.1 Global Ex Vivo Human Skin Models Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Pharmaceutical
1.3.3 Cosmetic
1.3.4 Others
1.4 Global Ex Vivo Human Skin Models Market Estimates and Forecasts (2021-2032)
1.4.1 Global Ex Vivo Human Skin Models Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Ex Vivo Human Skin Models Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Ex Vivo Human Skin Models Price Trends (2021-2032)
1.5 Assumptions and Limitations

2 Market Size and Prospects by Region
2.1 Global Ex Vivo Human Skin Models Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Ex Vivo Human Skin Models Historical Market Scenario by Region (2021-2026)
2.2.1 Global Ex Vivo Human Skin Models Sales Market Share by Region (2021-2026)
2.2.2 Global Ex Vivo Human Skin Models Revenue Market Share by Region (2021-2026)
2.3 Global Ex Vivo Human Skin Models Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Ex Vivo Human Skin Models Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Ex Vivo Human Skin Models Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Ex Vivo Human Skin Models Market Size and Prospects (2021-2032)
2.4.2 Europe Ex Vivo Human Skin Models Market Size and Prospects (2021-2032)
2.4.3 China Ex Vivo Human Skin Models Market Size and Prospects (2021-2032)
2.4.4 Japan Ex Vivo Human Skin Models Market Size and Prospects (2021-2032)

3 Global Market Size by Type
3.1 Global Ex Vivo Human Skin Models Historical Market Review by Type (2021-2026)
3.1.1 Global Ex Vivo Human Skin Models Sales by Type (2021-2026)
3.1.2 Global Ex Vivo Human Skin Models Revenue by Type (2021-2026)
3.1.3 Global Ex Vivo Human Skin Models Average Price by Type (2021-2026)
3.2 Global Ex Vivo Human Skin Models Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Ex Vivo Human Skin Models Sales Forecast by Type (2027-2032)
3.2.2 Global Ex Vivo Human Skin Models Revenue Forecast by Type (2027-2032)
3.2.3 Global Ex Vivo Human Skin Models Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Ex Vivo Human Skin Models

4 Global Market Size by Application
4.1 Global Ex Vivo Human Skin Models Historical Market Review by Application (2021-2026)
4.1.1 Global Ex Vivo Human Skin Models Sales by Application (2021-2026)
4.1.2 Global Ex Vivo Human Skin Models Revenue by Application (2021-2026)
4.1.3 Global Ex Vivo Human Skin Models Average Price by Application (2021-2026)
4.2 Global Ex Vivo Human Skin Models Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Ex Vivo Human Skin Models Sales Forecast by Application (2027-2032)
4.2.2 Global Ex Vivo Human Skin Models Revenue Forecast by Application (2027-2032)
4.2.3 Global Ex Vivo Human Skin Models Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Ex Vivo Human Skin Models Applications

5 Competition Landscape by Players
5.1 Global Ex Vivo Human Skin Models Sales by Player (2021-2026)
5.2 Global Top Ex Vivo Human Skin Models Players by Revenue (2021-2026)
5.3 Global Ex Vivo Human Skin Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Ex Vivo Human Skin Models revenue as of 2025
5.4 Global Ex Vivo Human Skin Models Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Ex Vivo Human Skin Models, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Ex Vivo Human Skin Models, Product Type & Application
5.7 Global Key Manufacturers of Ex Vivo Human Skin Models, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Ex Vivo Human Skin Models Sales by Company
6.1.1.1 North America Ex Vivo Human Skin Models Sales by Company (2021-2026)
6.1.1.2 North America Ex Vivo Human Skin Models Revenue by Company (2021-2026)
6.1.2 North America Ex Vivo Human Skin Models Sales Breakdown by Type (2021-2026)
6.1.3 North America Ex Vivo Human Skin Models Sales Breakdown by Application (2021-2026)
6.1.4 North America Ex Vivo Human Skin Models Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Ex Vivo Human Skin Models Sales by Company
6.2.1.1 Europe Ex Vivo Human Skin Models Sales by Company (2021-2026)
6.2.1.2 Europe Ex Vivo Human Skin Models Revenue by Company (2021-2026)
6.2.2 Europe Ex Vivo Human Skin Models Sales Breakdown by Type (2021-2026)
6.2.3 Europe Ex Vivo Human Skin Models Sales Breakdown by Application (2021-2026)
6.2.4 Europe Ex Vivo Human Skin Models Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Ex Vivo Human Skin Models Sales by Company
6.3.1.1 China Ex Vivo Human Skin Models Sales by Company (2021-2026)
6.3.1.2 China Ex Vivo Human Skin Models Revenue by Company (2021-2026)
6.3.2 China Ex Vivo Human Skin Models Sales Breakdown by Type (2021-2026)
6.3.3 China Ex Vivo Human Skin Models Sales Breakdown by Application (2021-2026)
6.3.4 China Ex Vivo Human Skin Models Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Ex Vivo Human Skin Models Sales by Company
6.4.1.1 Japan Ex Vivo Human Skin Models Sales by Company (2021-2026)
6.4.1.2 Japan Ex Vivo Human Skin Models Revenue by Company (2021-2026)
6.4.2 Japan Ex Vivo Human Skin Models Sales Breakdown by Type (2021-2026)
6.4.3 Japan Ex Vivo Human Skin Models Sales Breakdown by Application (2021-2026)
6.4.4 Japan Ex Vivo Human Skin Models Major Customers
6.4.5 Japan Market Trends and Opportunities

7 Company Profiles and Key Figures
7.1 Genoskin
7.1.1 Genoskin Company Information
7.1.2 Genoskin Business Overview
7.1.3 Genoskin Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Genoskin Ex Vivo Human Skin Models Products Offered
7.1.5 Genoskin Recent Development
7.2 MatTek Life Sciences
7.2.1 MatTek Life Sciences Company Information
7.2.2 MatTek Life Sciences Business Overview
7.2.3 MatTek Life Sciences Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.2.4 MatTek Life Sciences Ex Vivo Human Skin Models Products Offered
7.2.5 MatTek Life Sciences Recent Development
7.3 Creative Bioarray
7.3.1 Creative Bioarray Company Information
7.3.2 Creative Bioarray Business Overview
7.3.3 Creative Bioarray Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Creative Bioarray Ex Vivo Human Skin Models Products Offered
7.3.5 Creative Bioarray Recent Development
7.4 EpiSkin
7.4.1 EpiSkin Company Information
7.4.2 EpiSkin Business Overview
7.4.3 EpiSkin Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.4.4 EpiSkin Ex Vivo Human Skin Models Products Offered
7.4.5 EpiSkin Recent Development
7.5 Reprocell
7.5.1 Reprocell Company Information
7.5.2 Reprocell Business Overview
7.5.3 Reprocell Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Reprocell Ex Vivo Human Skin Models Products Offered
7.5.5 Reprocell Recent Development
7.6 Alcyomics
7.6.1 Alcyomics Company Information
7.6.2 Alcyomics Business Overview
7.6.3 Alcyomics Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Alcyomics Ex Vivo Human Skin Models Products Offered
7.6.5 Alcyomics Recent Development
7.7 Epistem
7.7.1 Epistem Company Information
7.7.2 Epistem Business Overview
7.7.3 Epistem Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Epistem Ex Vivo Human Skin Models Products Offered
7.7.5 Epistem Recent Development
7.8 QIMA Life Sciences
7.8.1 QIMA Life Sciences Company Information
7.8.2 QIMA Life Sciences Business Overview
7.8.3 QIMA Life Sciences Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.8.4 QIMA Life Sciences Ex Vivo Human Skin Models Products Offered
7.8.5 QIMA Life Sciences Recent Development
7.9 Extherid Biosciences
7.9.1 Extherid Biosciences Company Information
7.9.2 Extherid Biosciences Business Overview
7.9.3 Extherid Biosciences Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Extherid Biosciences Ex Vivo Human Skin Models Products Offered
7.9.5 Extherid Biosciences Recent Development
7.10 Perfectus Biomed
7.10.1 Perfectus Biomed Company Information
7.10.2 Perfectus Biomed Business Overview
7.10.3 Perfectus Biomed Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Perfectus Biomed Ex Vivo Human Skin Models Products Offered
7.10.5 Perfectus Biomed Recent Development
7.11 Xenometrix
7.11.1 Xenometrix Company Information
7.11.2 Xenometrix Business Overview
7.11.3 Xenometrix Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Xenometrix Ex Vivo Human Skin Models Products Offered
7.11.5 Xenometrix Recent Development
7.12 Syntivia
7.12.1 Syntivia Company Information
7.12.2 Syntivia Business Overview
7.12.3 Syntivia Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Syntivia Ex Vivo Human Skin Models Products Offered
7.12.5 Syntivia Recent Development
7.13 Creative Biolabs
7.13.1 Creative Biolabs Company Information
7.13.2 Creative Biolabs Business Overview
7.13.3 Creative Biolabs Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Creative Biolabs Ex Vivo Human Skin Models Products Offered
7.13.5 Creative Biolabs Recent Development

8 Ex Vivo Human Skin Models Manufacturing Cost Analysis
8.1 Ex Vivo Human Skin Models Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Ex Vivo Human Skin Models
8.4 Ex Vivo Human Skin Models Industrial Chain Analysis

9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Ex Vivo Human Skin Models Distributors List
9.3 Ex Vivo Human Skin Models Customers

10 Ex Vivo Human Skin Models Market Dynamics
10.1 Ex Vivo Human Skin Models Industry Trends
10.2 Ex Vivo Human Skin Models Market Drivers
10.3 Ex Vivo Human Skin Models Market Challenges
10.4 Ex Vivo Human Skin Models Market Restraints

11 Research Findings and Conclusion

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Ex Vivo Human Skin Models Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Ex Vivo Human Skin Models Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Ex Vivo Human Skin Models Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Ex Vivo Human Skin Models Sales (K Units) by Region (2021-2026)
Table 5. Global Ex Vivo Human Skin Models Sales Market Share by Region (2021-2026)
Table 6. Global Ex Vivo Human Skin Models Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Ex Vivo Human Skin Models Revenue Share by Region (2021-2026)
Table 8. Global Ex Vivo Human Skin Models Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Ex Vivo Human Skin Models Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Ex Vivo Human Skin Models Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Ex Vivo Human Skin Models Revenue Share Forecast by Region (2027-2032)
Table 12. Global Ex Vivo Human Skin Models Sales by Type (K Units) & (2021-2026)
Table 13. Global Ex Vivo Human Skin Models Sales Share by Type (2021-2026)
Table 14. Global Ex Vivo Human Skin Models Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Ex Vivo Human Skin Models Average Price by Type (US$/Unit) & (2021-2026)
Table 16. Global Ex Vivo Human Skin Models Sales by Type (K Units) & (2027-2032)
Table 17. Global Ex Vivo Human Skin Models Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Ex Vivo Human Skin Models Average Price by Type (US$/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Ex Vivo Human Skin Models Sales by Application (K Units) & (2021-2026)
Table 21. Global Ex Vivo Human Skin Models Sales Share by Application (2021-2026)
Table 22. Global Ex Vivo Human Skin Models Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Ex Vivo Human Skin Models Average Price by Application (US$/Unit) & (2021-2026)
Table 24. Global Ex Vivo Human Skin Models Sales by Application (K Units) & (2027-2032)
Table 25. Global Ex Vivo Human Skin Models Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Ex Vivo Human Skin Models Average Price by Application (US$/Unit) & (2027-2032)
Table 27. New Sources of Growth in Ex Vivo Human Skin Models Applications
Table 28. Global Ex Vivo Human Skin Models Sales by Company (K Units) & (2021-2026)
Table 29. Global Ex Vivo Human Skin Models Sales Share by Company (2021-2026)
Table 30. Global Ex Vivo Human Skin Models Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Ex Vivo Human Skin Models Revenue Share by Company (2021-2026)
Table 32. Global Ex Vivo Human Skin Models by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ex Vivo Human Skin Models as of 2025)
Table 33. Global Market Ex Vivo Human Skin Models Average Price by Company (US$/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Ex Vivo Human Skin Models, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Ex Vivo Human Skin Models, Product Type & Application
Table 36. Global Key Manufacturers of Ex Vivo Human Skin Models, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Ex Vivo Human Skin Models Sales by Company (2021-2026) & (K Units)
Table 39. North America Ex Vivo Human Skin Models Sales Market Share by Company (2021-2026)
Table 40. North America Ex Vivo Human Skin Models Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Ex Vivo Human Skin Models Revenue Market Share by Company (2021-2026)
Table 42. North America Ex Vivo Human Skin Models Sales by Type (2021-2026) & (K Units)
Table 43. North America Ex Vivo Human Skin Models Sales Market Share by Type (2021-2026)
Table 44. North America Ex Vivo Human Skin Models Sales by Application (2021-2026) & (K Units)
Table 45. North America Ex Vivo Human Skin Models Sales Market Share by Application (2021-2026)
Table 46. Europe Ex Vivo Human Skin Models Sales by Company (2021-2026) & (K Units)
Table 47. Europe Ex Vivo Human Skin Models Sales Market Share by Company (2021-2026)
Table 48. Europe Ex Vivo Human Skin Models Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Ex Vivo Human Skin Models Revenue Market Share by Company (2021-2026)
Table 50. Europe Ex Vivo Human Skin Models Sales by Type (2021-2026) & (K Units)
Table 51. Europe Ex Vivo Human Skin Models Sales Market Share by Type (2021-2026)
Table 52. Europe Ex Vivo Human Skin Models Sales by Application (2021-2026) & (K Units)
Table 53. Europe Ex Vivo Human Skin Models Sales Market Share by Application (2021-2026)
Table 54. China Ex Vivo Human Skin Models Sales by Company (2021-2026) & (K Units)
Table 55. China Ex Vivo Human Skin Models Sales Market Share by Company (2021-2026)
Table 56. China Ex Vivo Human Skin Models Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Ex Vivo Human Skin Models Revenue Market Share by Company (2021-2026)
Table 58. China Ex Vivo Human Skin Models Sales by Type (2021-2026) & (K Units)
Table 59. China Ex Vivo Human Skin Models Sales Market Share by Type (2021-2026)
Table 60. China Ex Vivo Human Skin Models Sales by Application (2021-2026) & (K Units)
Table 61. China Ex Vivo Human Skin Models Sales Market Share by Application (2021-2026)
Table 62. Japan Ex Vivo Human Skin Models Sales by Company (2021-2026) & (K Units)
Table 63. Japan Ex Vivo Human Skin Models Sales Market Share by Company (2021-2026)
Table 64. Japan Ex Vivo Human Skin Models Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Ex Vivo Human Skin Models Revenue Market Share by Company (2021-2026)
Table 66. Japan Ex Vivo Human Skin Models Sales by Type (2021-2026) & (K Units)
Table 67. Japan Ex Vivo Human Skin Models Sales Market Share by Type (2021-2026)
Table 68. Japan Ex Vivo Human Skin Models Sales by Application (2021-2026) & (K Units)
Table 69. Japan Ex Vivo Human Skin Models Sales Market Share by Application (2021-2026)
Table 70. Genoskin Company Information
Table 71. Genoskin Description and Business Overview
Table 72. Genoskin Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 73. Genoskin Ex Vivo Human Skin Models Product
Table 74. Genoskin Recent Development
Table 75. MatTek Life Sciences Company Information
Table 76. MatTek Life Sciences Description and Business Overview
Table 77. MatTek Life Sciences Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. MatTek Life Sciences Ex Vivo Human Skin Models Product
Table 79. MatTek Life Sciences Recent Development
Table 80. Creative Bioarray Company Information
Table 81. Creative Bioarray Description and Business Overview
Table 82. Creative Bioarray Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Creative Bioarray Ex Vivo Human Skin Models Product
Table 84. Creative Bioarray Recent Development
Table 85. EpiSkin Company Information
Table 86. EpiSkin Description and Business Overview
Table 87. EpiSkin Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. EpiSkin Ex Vivo Human Skin Models Product
Table 89. EpiSkin Recent Development
Table 90. Reprocell Company Information
Table 91. Reprocell Description and Business Overview
Table 92. Reprocell Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Reprocell Ex Vivo Human Skin Models Product
Table 94. Reprocell Recent Development
Table 95. Alcyomics Company Information
Table 96. Alcyomics Description and Business Overview
Table 97. Alcyomics Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Alcyomics Ex Vivo Human Skin Models Product
Table 99. Alcyomics Recent Development
Table 100. Epistem Company Information
Table 101. Epistem Description and Business Overview
Table 102. Epistem Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Epistem Ex Vivo Human Skin Models Product
Table 104. Epistem Recent Development
Table 105. QIMA Life Sciences Company Information
Table 106. QIMA Life Sciences Description and Business Overview
Table 107. QIMA Life Sciences Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. QIMA Life Sciences Ex Vivo Human Skin Models Product
Table 109. QIMA Life Sciences Recent Development
Table 110. Extherid Biosciences Company Information
Table 111. Extherid Biosciences Description and Business Overview
Table 112. Extherid Biosciences Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Extherid Biosciences Ex Vivo Human Skin Models Product
Table 114. Extherid Biosciences Recent Development
Table 115. Perfectus Biomed Company Information
Table 116. Perfectus Biomed Description and Business Overview
Table 117. Perfectus Biomed Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Perfectus Biomed Ex Vivo Human Skin Models Product
Table 119. Perfectus Biomed Recent Development
Table 120. Xenometrix Company Information
Table 121. Xenometrix Description and Business Overview
Table 122. Xenometrix Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Xenometrix Ex Vivo Human Skin Models Product
Table 124. Xenometrix Recent Development
Table 125. Syntivia Company Information
Table 126. Syntivia Description and Business Overview
Table 127. Syntivia Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Syntivia Ex Vivo Human Skin Models Product
Table 129. Syntivia Recent Development
Table 130. Creative Biolabs Company Information
Table 131. Creative Biolabs Description and Business Overview
Table 132. Creative Biolabs Ex Vivo Human Skin Models Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Creative Biolabs Ex Vivo Human Skin Models Product
Table 134. Creative Biolabs Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Ex Vivo Human Skin Models Distributors List
Table 138. Ex Vivo Human Skin Models Customers List
Table 139. Ex Vivo Human Skin Models Market Trends
Table 140. Ex Vivo Human Skin Models Market Drivers
Table 141. Ex Vivo Human Skin Models Market Challenges
Table 142. Ex Vivo Human Skin Models Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources

List of Figures
Figure 1. Ex Vivo Human Skin Models Product Picture
Figure 2. Global Ex Vivo Human Skin Models Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Ex Vivo Human Skin Models Sales Market Share by Type in 2025 & 2032
Figure 4. Products Product Picture
Figure 5. Customized Testing Services Product Picture
Figure 6. Global Ex Vivo Human Skin Models Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 7. Global Ex Vivo Human Skin Models Sales Market Share by Application in 2025 & 2032
Figure 8. Pharmaceutical Examples
Figure 9. Cosmetic Examples
Figure 10. Others Examples
Figure 11. Global Ex Vivo Human Skin Models Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global Ex Vivo Human Skin Models Sales Growth Rate (2021-2032) & (US$ Million)
Figure 13. Global Ex Vivo Human Skin Models Sales (K Units) Growth Rate (2021-2032)
Figure 14. Global Ex Vivo Human Skin Models Price Trends Growth Rate (2021-2032) & (US$/Unit)
Figure 15. Ex Vivo Human Skin Models Report Years Considered
Figure 16. Global Market Ex Vivo Human Skin Models Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 17. Global Ex Vivo Human Skin Models Revenue Market Share by Region: 2021 VS 2025
Figure 18. North America Ex Vivo Human Skin Models Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. North America Ex Vivo Human Skin Models Sales (K Units) Growth Rate (2021-2032)
Figure 20. Europe Ex Vivo Human Skin Models Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Europe Ex Vivo Human Skin Models Sales (K Units) Growth Rate (2021-2032)
Figure 22. China Ex Vivo Human Skin Models Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. China Ex Vivo Human Skin Models Sales (K Units) Growth Rate (2021-2032)
Figure 24. Japan Ex Vivo Human Skin Models Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. Japan Ex Vivo Human Skin Models Sales (K Units) Growth Rate (2021-2032)
Figure 26. Global Ex Vivo Human Skin Models Revenue Share by Type (2021-2026)
Figure 27. Global Ex Vivo Human Skin Models Sales Share by Type (2027-2032)
Figure 28. Global Ex Vivo Human Skin Models Revenue Share by Type (2027-2032)
Figure 29. Global Ex Vivo Human Skin Models Revenue Share by Application (2021-2026)
Figure 30. Global Ex Vivo Human Skin Models Revenue Market Share by Application in 2021 & 2025
Figure 31. Global Ex Vivo Human Skin Models Sales Share by Application (2027-2032)
Figure 32. Global Ex Vivo Human Skin Models Revenue Share by Application (2027-2032)
Figure 33. Global Ex Vivo Human Skin Models Sales Share by Company (2025)
Figure 34. Global Ex Vivo Human Skin Models Revenue Share by Company (2025)
Figure 35. Global 5 Largest Ex Vivo Human Skin Models Players Market Share by Revenue in Ex Vivo Human Skin Models: 2021 & 2025
Figure 36. Ex Vivo Human Skin Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 37. Manufacturing Cost Structure of Ex Vivo Human Skin Models
Figure 38. Manufacturing Process Analysis of Ex Vivo Human Skin Models
Figure 39. Ex Vivo Human Skin Models Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed